查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594615

肿瘤 NGS 市场：按技术、产品和服务、应用分类 - 2025-2030 年全球预测

Oncology NGS Market by Technology (Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing), Product & Service (Platforms & Related Products, Services), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肿瘤NGS市值为4.3826亿美元，预计到2024年将达到5.0437亿美元，复合年增长率为15.48%，到2030年将达到123.9万美元。

肿瘤学中的次世代定序仪（NGS）是一种先进技术，用于比传统方法更快、更经济地分析癌症基因组，提供个人化癌症治疗所需的详细见解，涉及特定的基因组定序技术。肿瘤学领域的 NGS 市场是由对精准医疗不断增长的需求推动的，因为它能够识别特定的基因突变并有助于客製化标靶治疗，这对于有效的癌症管理至关重要。该应用正在扩展到各种最终用途，包括利用 NGS 进行诊断、治疗方法决策和监测患者进展的医院、研究机构和製药公司。影响市场成长的治疗因素包括NGS平台的技术进步显着降低了定序成本、全球癌症发生率上升需要精确的治疗策略以及政府和私人对基因组研究的资助增加等。然而，市场受到资料解释的高度复杂性、严格的法律规范以及建立 NGS 实验室的初始资本成本高等挑战的限制。儘管存在这些挑战，但透过与生物资讯公司合作来管理和解释 NGS资料以及协作研究，从而产生创新的 NGS 特定诊断和治疗解决方案，仍然存在发展机会。此外，解决现有基础设施差距也带来了成长潜力，尤其是在新兴市场。业务成长包括开发用户友好的生物资讯学工具、增强多重检测能力以在单次检测中涵盖更多基因，以及探索液态切片技术作为非侵入性诊断解决方案，这些都是创新的成熟领域。鑑于市场的动态性，随时了解最新的技术进步、监管环境的变化以及竞争格局的变化对于识别和抓住机会至关重要。总体而言，肿瘤学 NGS 市场对于优先考虑敏捷适应和持续创新的公司来说具有巨大的潜力。

主要市场统计
基准年[2023] 4.3826亿美元
预测年份 [2024] 5.0437 亿美元
预测年份 [2030] 12.39亿美元
复合年增长率（%） 15.48%

市场动态：揭示快速发展的肿瘤学 NGS 市场的关键市场洞察

肿瘤学 NGS 市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球癌症发生率上升所带来的潜在需求
    • 个人化医疗在临床肿瘤学中日益普及
    • 由于基因序列测定解决方案成本降低，消费者采用率提高
  • 市场限制因素
    • 资料管理缺乏计算效率
  • 市场机会
    • 政府加大对肿瘤研发领域的努力与投资
    • 全基因组定序领域的进展
  • 市场问题
    • 报销政策有限且不充分

波特五力：开拓肿瘤 NGS 市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肿瘤 NGS 市场的外部影响

外部宏观环境因素在塑造肿瘤NGS市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解肿瘤NGS市场的竞争格局

肿瘤学 NGS 市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：肿瘤 NGS 市场供应商的绩效评估

FPNV定位矩阵是评估肿瘤NGS市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製肿瘤 NGS 市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，肿瘤 NGS 市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率上升导致潜在需求增加
      • 个人化医疗在临床肿瘤学中日益普及
      • 基因定序解决方案成本降低，消费者采用率提高
    • 抑制因素
      • 资料管理缺乏计算效率
    • 机会
      • 政府加大对肿瘤研发领域的努力与投资
      • 全球全基因组定序新进展
    • 任务
      • 退款政策有限且不充分
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章肿瘤学 NGS 市场：依技术分类

  • 介绍
  • 扩增子碱基
  • 混合基地
  • 标靶和基因组定序
  • 全EXOME序列分析
  • 全基因组序列分析

第 7 章肿瘤学 NGS 市场：依产品与服务分类

  • 介绍
  • 平台及相关产品
    • 消耗品
    • 控制板
    • 平台
  • 服务
    • 按工作流程
    • NGS资料分析
    • NGS预测序
    • NGS原始资料分析
    • NGS二次资料分析
    • NGS定序
    • NGS三级资料分析

第 8 章肿瘤学 NGS 市场：依应用分类

  • 介绍
  • 学术和临床研究
  • 医院/诊所
  • 製药和生物技术公司

第9章美洲肿瘤NGS市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太肿瘤NGS市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的肿瘤NGS市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 4basecare Onco Solutions Private Limited
  • BGI Group
  • Caris Life Sciences
  • Eurofins Scientific SE
  • Foundation Medicine, Inc.
  • Genotypic Technology Pvt. Ltd.
  • Hologic, Inc.
  • MedGenome
  • Myriad Genetics, Inc.
  • PerkinElmer Inc.
  • Premas Life Sciences
  • Sayre Therapeutics Pvt Ltd.
  • SciGenom Labs Pvt. Ltd.
  • Tecan Trading AG
  • Vela Diagnostics Holding Pte Ltd.
  • Xcelris Labs Ltd.
Product Code: MRR-3A2E844FECAB

The Oncology NGS Market was valued at USD 438.26 million in 2023, expected to reach USD 504.37 million in 2024, and is projected to grow at a CAGR of 15.48%, to USD 1,200.39 million by 2030.

Oncology Next-Generation Sequencing (NGS) refers to advanced genomic sequencing technologies used to analyze cancer genomes more swiftly and economically than traditional methods, providing detailed insights necessary for personalized cancer treatment. The NGS market in oncology is driven by the increasing demand for precision medicine, as it allows for the identification of specific genetic mutations and helps tailor targeted therapies, essential for effective cancer management. This application extends across various end uses like hospitals, research institutions, and pharmaceutical companies who utilize NGS for diagnostics, therapy decisions, and monitoring patient progress. Factors influencing market growth include the technological advancements in NGS platforms that have significantly reduced sequencing costs, rising incidences of cancer globally necessitating precise treatment strategies, and increasing government and private funding in genomic research. However, the market faces limitations from challenges such as the high complexity involved in data interpretation, stringent regulatory frameworks, and the high initial investment cost for setting up NGS laboratories. Despite these challenges, evolving opportunities exist through partnerships with bioinformatics companies to manage and interpret NGS data, and through collaborations that lead to innovative NGS-based diagnostic and therapeutic solutions. Furthermore, addressing gaps in the existing infrastructure, especially in emerging markets, presents growth potential. For business growth, areas ripe for innovation include the development of user-friendly bioinformatics tools, enhancement in multiplexing capabilities to cover more genes in a single assay, and the exploration of liquid biopsy technologies as a non-invasive diagnostic solution. Given the dynamic nature of the market, staying informed of the latest technological advancements, regulatory changes, and competitive landscape shifts is crucial for identifying and seizing opportunities. Overall, the market for oncology NGS holds significant promise for businesses that prioritize agile adaptation and continuous innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 438.26 million
Estimated Year [2024] USD 504.37 million
Forecast Year [2030] USD 1,200.39 million
CAGR (%) 15.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology NGS Market

The Oncology NGS Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential demand attributed to rising prevalence of cancer incidence globally
    • Growing popularity of personalized medicine in clinical oncology
    • Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
  • Market Restraints
    • Lack of computational efficiency for data management
  • Market Opportunities
    • Rising governmental initiatives and investments in the field of research and development in oncology
    • Emerging advancements for whole-genome sequencing worldwide
  • Market Challenges
    • Limited and inadequate reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Oncology NGS Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology NGS Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology NGS Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology NGS Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology NGS Market

A detailed market share analysis in the Oncology NGS Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology NGS Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology NGS Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology NGS Market

A strategic analysis of the Oncology NGS Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology NGS Market, highlighting leading vendors and their innovative profiles. These include 4basecare Onco Solutions Private Limited, BGI Group, Caris Life Sciences, Eurofins Scientific SE, Foundation Medicine, Inc., Genotypic Technology Pvt. Ltd., Hologic, Inc., MedGenome, Myriad Genetics, Inc., PerkinElmer Inc., Premas Life Sciences, Sayre Therapeutics Pvt Ltd., SciGenom Labs Pvt. Ltd., Tecan Trading AG, Vela Diagnostics Holding Pte Ltd., and Xcelris Labs Ltd..

Market Segmentation & Coverage

This research report categorizes the Oncology NGS Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Product & Service, market is studied across Platforms & Related Products and Services. The Platforms & Related Products is further studied across Consumables, Panels, and Platforms. The Services is further studied across By Workflow, NGS Data Analysis, NGS Pre-Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Sequencing, and NGS Tertiary Data Analysis.
  • Based on Application, market is studied across Academic & Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to rising prevalence of cancer incidence globally
      • 5.1.1.2. Growing popularity of personalized medicine in clinical oncology
      • 5.1.1.3. Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of computational efficiency for data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising governmental initiatives and investments in the field of research and development in oncology
      • 5.1.3.2. Emerging advancements for whole-genome sequencing worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Limited and inadequate reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oncology NGS Market, by Technology

  • 6.1. Introduction
  • 6.2. Amplicon-based
  • 6.3. Hybridization-based
  • 6.4. Targeted & Gene Panel Sequencing
  • 6.5. Whole Exome Sequencing
  • 6.6. Whole Genome Sequencing

7. Oncology NGS Market, by Product & Service

  • 7.1. Introduction
  • 7.2. Platforms & Related Products
    • 7.2.1. Consumables
    • 7.2.2. Panels
    • 7.2.3. Platforms
  • 7.3. Services
    • 7.3.1. By Workflow
    • 7.3.2. NGS Data Analysis
    • 7.3.3. NGS Pre-Sequencing
    • 7.3.4. NGS Primary Data Analysis
    • 7.3.5. NGS Secondary Data Analysis
    • 7.3.6. NGS Sequencing
    • 7.3.7. NGS Tertiary Data Analysis

8. Oncology NGS Market, by Application

  • 8.1. Introduction
  • 8.2. Academic & Clinical Research
  • 8.3. Hospitals & Clinics
  • 8.4. Pharma & Biotech Entities

9. Americas Oncology NGS Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oncology NGS Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oncology NGS Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4basecare Onco Solutions Private Limited
  • 2. BGI Group
  • 3. Caris Life Sciences
  • 4. Eurofins Scientific SE
  • 5. Foundation Medicine, Inc.
  • 6. Genotypic Technology Pvt. Ltd.
  • 7. Hologic, Inc.
  • 8. MedGenome
  • 9. Myriad Genetics, Inc.
  • 10. PerkinElmer Inc.
  • 11. Premas Life Sciences
  • 12. Sayre Therapeutics Pvt Ltd.
  • 13. SciGenom Labs Pvt. Ltd.
  • 14. Tecan Trading AG
  • 15. Vela Diagnostics Holding Pte Ltd.
  • 16. Xcelris Labs Ltd.

LIST OF FIGURES

  • FIGURE 1. ONCOLOGY NGS MARKET RESEARCH PROCESS
  • FIGURE 2. ONCOLOGY NGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ONCOLOGY NGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 242. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023